Diabetes News and Research

Latest Diabetes News and Research

65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases

Government and private sector health experts now estimate that 65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases such as diabetes and hypertension. The link between obesity and hypertension is well known, but the exact nature of the association between the two disorders remains unclear.

11 Jun 2004

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Researchers at the University of Illinois at Chicago are launching a clinical trial to determine whether a drug commonly used for diabetes might be effective in treating multiple sclerosis, an autoimmune disease that affects 350,000 Americans.

10 Jun 2004

Breath test device detects early symptoms of diabetes

John Plodinec and Chuji Wang already have developed a prototype and applied for a patent. They now are seeking a commercial partner to help them move their unique diabetes breath analyzer from the university laboratory into the marketplace.

10 Jun 2004

Higher-than-normal amounts of a selenium-containing enzyme could promote type 2 diabetes

A study by researchers at Cornell University suggests that higher-than-normal amounts of a selenium-containing enzyme could promote type 2 diabetes.

10 Jun 2004

£20 million funding for stem cell research in the UK

Scientists at Oxford will benefit from a share of a £20 million cross-research council investment in stem cell research which was announced last month.

9 Jun 2004

Advertising restrcitions on some over the counter medicines likely to be lifted

Regulations to remove the current ban on advertising certain over the counter (OTC) medicines to the public were laid in Parliament today

9 Jun 2004

Foundation for poor heart health laid early in life

Heart disease - long viewed as a scourge of adulthood - is a growing threat to children because of soaring rates of obesity and related problems, such as diabetes.

9 Jun 2004

Junk food manufacturers should be banned from targeting unhealthy products at children

The BMA's Annual Conference of Public Health Medicine called on the government to ban television advertising of junk foods before the watershed, and on all channels aimed at children.

7 Jun 2004

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

GenoMed, Inc., a Next Generation DM™ (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today the launch of its national marketing campaign to improve patient outcomes for diabetes, high blood pressure and emphysema.

7 Jun 2004

Obesity threatens health of women in nations previously not known for a growing percentage of overweight citizens

Around the globe, obesity has become a problem for many poorer women in most countries with upper-middle income national economies and even some with lower-middle income economies, an important new international study concludes.

7 Jun 2004

Better co-ordination needed to manage chronic diseases

A working party report released today calls for the co-ordinated management of chronic disease across primary and secondary care in the UK.

7 Jun 2004

Study looks at between inhalation of small particles, reduced heart rate variability and death

A study by Oak Ridge National Laboratory and partners might help explain whether there is a relationship between inhalation of small particles, reduced heart rate variability and death.

7 Jun 2004

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Research presented today showed that the investigational drug, LAF237, the first in a new class, improved glycemic control in patients with type 2 diabetes. In this study, LAF237, which is administered as a tablet to be taken orally, was added to the standard diabetes treatment metformin in patients whose diabetes was not adequately controlled by metformin alone.

7 Jun 2004

Treatment with atorvastatin cut incidence of stroke by almost a half

Patients with Type 2 diabetes and a CV risk factor would benefit from a cholesterol-lowering medicine according to results from the first ever specifically designed UK primary prevention statin trial announced today at the American Diabetes Association (ADA)2.

7 Jun 2004

Mission to promote diabetes care, prevention and a cure worldwide

The International Diabetes Federation (IDF) is taking the opportunity of the 64th American Diabetes Association’s Scientific Sessions to announce its new mission statement that has recently been decided by its Executive Board.

6 Jun 2004

Combination treatment may help type 2 diabetes patients

New research presented by Peter Weissman, M.D., from the University of Miami, at the 64th Annual Scientific Sessions of the American Diabetes Association shows that combination treatment with rosiglitazone maleate and metformin significantly improves certain markers of cardiovascular disease risk in patients with type 2 diabetes compared to metformin alone.

6 Jun 2004

Overweight families unaware & unconcerned about risk of diabetes and premature heart disease

Two new studies show that many children are at high risk for diabetes and premature heart disease, according to British and U.S. reports here today at the American Diabetes Association's 64th Annual Scientific Sessions.

5 Jun 2004

Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in the US

Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in this country. Tired of playing the low-fat game only to see our belt sizes increase, Americans have looked for other macronutrients as the reason behind their growing waists.

5 Jun 2004

Depression, insulin regimen linked to poor diabetes control

In the largest study of diabetes and depression conducted to date, researchers at Duke University Medical Center have found a clear link between the complexity of the self-care regimens in patients with diabetes and the effect of depression on diabetes control.

5 Jun 2004

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company have presented detailed 30-week data from two of the three pivotal Phase 3 studies of exenatide during a late-breaking session at the American Diabetes Association's (ADA) 64th Scientific Sessions in Orlando, Florida.

5 Jun 2004

Diabetes News and Research

Latest Diabetes News and Research

65 percent of America’s adults are overweight and 31 percent of adults are obese and at risk for chronic diseases

Drug commonly used for diabetes might be effective in treating multiple sclerosis

Breath test device detects early symptoms of diabetes

Higher-than-normal amounts of a selenium-containing enzyme could promote type 2 diabetes

£20 million funding for stem cell research in the UK

Advertising restrcitions on some over the counter medicines likely to be lifted

Foundation for poor heart health laid early in life

Junk food manufacturers should be banned from targeting unhealthy products at children

GenoMed launches campaign to improve patient outcomes for diabetes, high blood pressure and emphysema

Obesity threatens health of women in nations previously not known for a growing percentage of overweight citizens

Better co-ordination needed to manage chronic diseases

Study looks at between inhalation of small particles, reduced heart rate variability and death

Investigational drug, LAF237 improved glycemic control in patients with type 2 diabetes

Treatment with atorvastatin cut incidence of stroke by almost a half

Mission to promote diabetes care, prevention and a cure worldwide

Combination treatment may help type 2 diabetes patients

Overweight families unaware & unconcerned about risk of diabetes and premature heart disease

Carbohydrates are the latest nutrient to be blamed for the rising incidence of obesity in the US

Depression, insulin regimen linked to poor diabetes control

Exenatide shows significant improvements in glucose control for people With type 2 diabetes

Effect of the 2020 COVID-19 lockdown on long-term health

‘Entry Point’ enzyme for COVID-19 higher in COPD patients and smokers

Combining Improved Ion Usage Efficiency with Data Independent Acquisition to Quantify Proteomes

Diabetes News and Research

Latest Diabetes News and Research

Newsletters you may be interested in